Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Custom MRI tool could show within weeks if pancreatic cancer treatment is working

About 60% of people diagnosed with pancreatic cancer don't qualify for surgery because their disease is too advanced. For these patients, treatment typically begins with chemotherapy, in the hope that the tumor will shrink enough to be surgically removed, which offers the best chance of long-term survival. A new clinical trial at The Ohio State University Comprehensive Cancer Center—Arthur G.…

Custom MRI tool could show within weeks if pancreatic cancer treatment is working

Pancreatic cancer often progresses too far for surgery, so chemotherapy is typically the first line of treatment. However, current imaging tools cannot quickly determine if chemotherapy is effective. A new clinical trial at Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute is testing a custom imaging tool called dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI).

This tool measures blood flow in tumors, providing early indications of treatment success. Led by medical oncologist Shafia Rahman, M.D., the trial will enroll 50 patients with pancreatic ductal adenocarcinoma that can be surgically removed. About 60% of pancreatic cancer patients do not qualify for surgery due to advanced disease.

Rahman explains that time is crucial, as even a couple of weeks can significantly impact outcomes. The trial will compare patients treated with standard chemotherapy to those with DCE-MRI, aiming to improve complete surgical resection rates. The DCE-MRI tool, developed by radiology scientist Harrison Kim, Ph.D., offers precise, standardized measurements, potentially improving treatment outcomes by enabling timely adjustments.

Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at medicalxpress.com →

More in Health & Medicine

Alzheimer’s Breakthrough Targets Genes That May Raise Risk up to 12 Times

Could an effective gene therapy for Alzheimer's be on the horizon? Dr. Kevin Kemp told Newsweek that he thinks so.

  • University of Bristol scientists develop gene therapy targeting APOE4 gene.
  • Therapy converts APOE4 to APOE3, reducing Alzheimer's risk up to 12 times.
  • Research led by Dr. Kevin Kemp shows promising results in human immune cells.

More from Friday 20 November →